Skip to main content
Livermore
Livermore
ZHEN

Intellectus Partners, LLC

SEC CIK
0001677253
Latest filing
Aug 12, 2026

RLAY holding history

Relay Therapeutics, Inc. in every 13F filed by Intellectus Partners, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

RLAY overviewAll 13F holders of RLAYFull Q2 2026 holdings

Shares (Q2 2026)
20,225
Value
$378.4K
% of portfolio
0.1%
Quarters held
22
Since Q1 2021
Holdings of RLAY by Intellectus Partners, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202620,225$378.4K0.1%−22,000−52.1%ReducedHolders
Q1 202642,225$420.1K0.1%−1,700−3.9%ReducedHolders
Q4 202543,925$371.6K0.1%−12,500−22.2%ReducedHolders
Q3 202556,425$294.5K0.1%−5,000−8.1%ReducedHolders
Q2 202561,425$212.5K<0.1%00.0%UnchangedHolders
Q1 202561,425$160.9K<0.1%00.0%UnchangedHolders
Q4 202461,425$253.1K0.1%−6,250−9.2%ReducedHolders
Q3 202467,675$479.1K0.1%00.0%UnchangedHolders
Q2 202467,675$441.2K0.1%−1,585−2.3%ReducedHolders
Q1 202469,260$574.9K0.2%+19,400+38.9%AddedHolders
Q4 202349,860$549.0K0.2%−700−1.4%ReducedHolders
Q3 202350,560$425.2K0.1%+2,000+4.1%AddedHolders
Q2 202348,560$609.9K0.2%+21,675+80.6%AddedHolders
Q1 202326,885$442.8K0.1%−1,900−6.6%ReducedHolders
Q4 202228,785$430.0K0.1%+2,800+10.8%AddedHolders
Q3 202225,985$581.0K0.2%+1,725+7.1%AddedHolders
Q2 202224,260$406.0K0.1%+1,790+8.0%AddedHolders
Q1 202222,470$673.0K0.2%−3,700−14.1%ReducedHolders
Q4 202126,170$804.0K0.2%−8,024−23.5%ReducedHolders
Q3 202134,194$1.08M0.3%+150+0.4%AddedHolders
Q2 202134,044$1.25M0.3%+9,189+37.0%AddedHolders
Q1 202124,855$859.0K0.2%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.